News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cancer Genetics, Inc. Granted Patent for Kidney Cancer Diagnosis & Typing Using a Proprietary Genomic Method


11/6/2013 9:40:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RUTHERFORD, N.J., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), a DNA based diagnostics company focused on developing genomic-based, oncology tests and services, received a formal Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application covering a panel of probes for use in its proprietary methods for the detection and differentiation of kidney cancer.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES